Safi Morteza, Khaheshi Isa, Memaryan Mehdi, Naderian Mohammadreza
Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran..
Acta Biomed. 2016 Jan 16;87(3):318-320.
Hemorrhagic complications of thrombolytic therapy are rare but also serious and sometimes life-threatening. Liver hematoma is a very uncommon complication following thrombolytic therapy. We present a rare case of sub-capsular liver hematoma following streptokinase therapy of acute myocardial infarction as a challenging condition. This case report highlights that emergency physicians and cardiologists should be familiar with the significant and uncommon complications of thrombolytic agents, particularly streptokinase which is used generally in under- developed countries.
溶栓治疗的出血并发症虽罕见,但也很严重,有时甚至危及生命。肝血肿是溶栓治疗后一种非常罕见的并发症。我们报告一例急性心肌梗死患者在接受链激酶治疗后发生肝包膜下血肿的罕见病例,这是一种具有挑战性的情况。本病例报告强调,急诊医生和心脏病专家应熟悉溶栓药物的重大且罕见的并发症,尤其是在欠发达国家普遍使用的链激酶。